AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Pharmaceutical compositions for induction of apoptosis of cancer cells and inhibition of reverse transcriptase of human immunodeficiency virus-1

Summary

Disclosed is the use of gold (III) complexes of porphyrins, Schiff-bases, bis(pyridyl)carboxamides and bis(pyridyl)sulfonamides as anti-tumor and anti-HIV agents.

Supplementary Information

Patent Number: TWI338692B
Application Number: TW2003125500A
Inventor: CHE CHIMING
Priority Date: 16 Sep 2002
Priority Number: TWI338692B
Application Date: 16 Sep 2003
Publication Date: 11 Mar 2011
IPC Current: C07D048722 | A61K0031555 | A61K00317072 | A61P003118 | A61P003500
Assignee Applicant: The University of Hong Kong
Title: Pharmaceutical compositions for induction of apoptosis of cancer cells and inhibition of reverse transcriptase of human immunodeficiency virus-1
Usefulness: Pharmaceutical compositions for induction of apoptosis of cancer cells and inhibition of reverse transcriptase of human immunodeficiency virus-1
Summary: (A) is useful to induce apoptosis of cancer cells and also to inhibit human immunodeficiency virus-1 reverse transcriptase (claimed).
Novelty: Use of gold (III) complex to induce apoptosis of cancer cells and to inhibit human immunodeficiency virus-1 reverse transcriptase

Industry

Biomedical

Sub Group

Medical Composition

Country/Region

Hong Kong

For more information, please click Here